Thesis
Tesla at $343.25 is mispriced, full stop. I know the signal score reads 44 out of 100 and the stock is down nearly a percent today, and I know the headline writers are asking if it is "time to buy" like they always do when the name is under pressure. But what the consensus is missing, what it always misses with Tesla, is the magnitude of the optionality sitting just beneath the surface. The Terafab AI chip initiative is not a side project. It is the foundation of Tesla's next $500 billion in market cap.
The Terafab Inflection
Let me cut straight to what matters this morning. The news that Tesla's Terafab AI chip push is meeting easing autonomy regulatory pressure is not a coincidence. It is convergence. Tesla has been building vertically integrated silicon capability for years, and now the regulatory environment is finally catching up to the technology. Intel rocketing 11.4% on Terafab partnership hopes tells you everything you need to know about how the market is pricing this opportunity for everyone except Tesla itself.
Think about what Terafab represents. Tesla is not just building cars. It is building the compute infrastructure to train and deploy autonomous systems at a scale no competitor can match. Custom silicon, proprietary training data from billions of real world miles, and now a softening regulatory posture that could accelerate the monetization timeline by quarters, not years. The market is valuing Tesla like a car company having a rough year. I am valuing it like a platform company on the cusp of unlocking recurring, software margin revenue streams.
The Numbers Nobody Wants to Discuss
Let me acknowledge the uncomfortable data. The signal score components are not screaming buy. Analyst sentiment sits at 49. News sentiment is 45. Insider activity is a dismal 14 out of 100. And the earnings component, while the strongest at 58, reflects a company that has only beaten estimates once in the last four quarters.
That insider score of 14 would normally give me pause. But context matters. Tesla insiders, Elon Musk in particular, have historically been poor timing indicators. The low insider buying here likely reflects lockup dynamics and capital allocation decisions around the Terafab buildout rather than a lack of conviction in the business trajectory. I have seen this pattern before with Tesla. Insiders go quiet right before inflection points because they know what is coming and the compliance window tightens.
The one beat in four quarters is a legitimate concern for the earnings purists. Margin trajectories have been under pressure as Tesla leaned into price cuts throughout 2025 to defend volume. But here is the thing. Gross margins on the vehicle side were always going to compress during this transition phase. The question is whether the new revenue vectors, autonomy licensing, AI compute services, energy storage, and Terafab chip sales to partners like Intel, can inflect fast enough to reaccelerate the consolidated margin profile. I believe they can.
Regulatory Tailwinds Are Real
The easing autonomy regulatory pressure is the catalyst that does not show up in a backward looking signal score. Washington has shifted. The framework is moving from "prove it is perfectly safe" to "prove it is safer than humans." That is a dramatically lower bar, and Tesla's dataset gives it an insurmountable advantage in clearing it. Every day of regulatory softening pulls forward the date when Tesla can flip the switch on full self driving revenue recognition at scale.
Walmart quietly building out EV charging infrastructure is another signal the ecosystem is maturing. When the largest retailer in the world is investing in solving EV owners' biggest pain point, it validates the secular demand thesis that underpins Tesla's volume story.
Why I Am Not at Full Conviction
I would be dishonest if I did not flag the risks. At $343.25, the stock is not cheap on any traditional metric. The delivery cadence needs to reaccelerate in Q2 and Q3 to justify current multiples before the Terafab and autonomy optionality kicks in. One beat in four quarters is not a trend I can ignore. And an insider score of 14 means the people closest to the company are not putting their own money to work at these levels, at least not visibly.
This is why my conviction sits at 72 rather than 90 plus. The setup is asymmetric, but the near term execution risk is real. Tesla needs to show that Terafab partnerships are generating revenue, not just headlines, within the next two to three quarters.
Bottom Line
Tesla at $343 with a 44 signal score is the market pricing in the pain of the last four quarters while ignoring the Terafab and autonomy catalysts that could redefine the company over the next four. I am bullish here, not because the chart looks pretty or because the quant signals are flashing green, but because the convergence of custom AI silicon, easing regulation, and ecosystem maturation creates an optionality profile that consensus simply refuses to underwrite. Buy the weakness. The inflection is closer than the signal score suggests.